Stericycle (NASDAQ:SRCL) had its price target lowered by equities researchers at Bank of America from $53.00 to $50.00 in a research report issued to clients and investors on Friday. The brokerage presently has an “underperform” rating on the business services provider’s stock. Bank of America’s price objective would suggest a potential upside of 5.69% from the stock’s previous close.
SRCL has been the subject of a number of other reports. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. BidaskClub cut shares of Stericycle from a “strong-buy” rating to a “buy” rating in a research report on Friday, September 14th. Robert W. Baird reduced their target price on shares of Stericycle from $70.00 to $56.00 and set a “neutral” rating for the company in a research report on Friday. BMO Capital Markets reduced their target price on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating for the company in a research report on Monday, August 6th. Finally, Barrington Research set a $72.00 target price on shares of Stericycle and gave the company a “buy” rating in a research report on Friday, October 5th. Five analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $66.88.
SRCL stock traded down $3.47 during midday trading on Friday, reaching $47.31. 4,278,847 shares of the company were exchanged, compared to its average volume of 1,002,569. The company has a debt-to-equity ratio of 0.87, a current ratio of 0.81 and a quick ratio of 0.81. Stericycle has a one year low of $46.44 and a one year high of $76.73. The stock has a market cap of $4.06 billion, a price-to-earnings ratio of 10.90, a price-to-earnings-growth ratio of 1.22 and a beta of 0.52.
Several institutional investors have recently made changes to their positions in the company. Gabelli Funds LLC boosted its position in shares of Stericycle by 7.9% in the third quarter. Gabelli Funds LLC now owns 137,000 shares of the business services provider’s stock valued at $8,039,000 after acquiring an additional 10,000 shares during the period. Gamco Investors INC. ET AL boosted its position in shares of Stericycle by 66.1% in the third quarter. Gamco Investors INC. ET AL now owns 20,107 shares of the business services provider’s stock valued at $1,180,000 after acquiring an additional 8,000 shares during the period. Bbva Compass Bancshares Inc. bought a new stake in shares of Stericycle in the third quarter valued at about $223,000. Markel Corp boosted its position in shares of Stericycle by 7.8% in the third quarter. Markel Corp now owns 399,500 shares of the business services provider’s stock valued at $23,443,000 after acquiring an additional 29,000 shares during the period. Finally, Zions Bancorporation bought a new stake in shares of Stericycle in the third quarter valued at about $130,000. 94.57% of the stock is owned by institutional investors.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Further Reading: What Are Treasury Bonds?
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.